- Home
- ELP vs LNTH Comparison
ELP vs LNTH Comparison
Compare ELP & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELP
- LNTH
- Stock Information
- Founded
- ELP 1954
- LNTH 1956
- Country
- ELP Brazil
- LNTH United States
- Employees
- ELP N/A
- LNTH N/A
- Industry
- ELP Electric Utilities: Central
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ELP Utilities
- LNTH Health Care
- Exchange
- ELP Nasdaq
- LNTH Nasdaq
- Market Cap
- ELP 5.5B
- LNTH 6.3B
- IPO Year
- ELP 1997
- LNTH 2015
- Fundamental
- Price
- ELP $6.15
- LNTH $94.05
- Analyst Decision
- ELP
- LNTH Strong Buy
- Analyst Count
- ELP 0
- LNTH 6
- Target Price
- ELP N/A
- LNTH $132.67
- AVG Volume (30 Days)
- ELP 231.6K
- LNTH 723.3K
- Earning Date
- ELP 02-27-2025
- LNTH 02-20-2025
- Dividend Yield
- ELP 4.09%
- LNTH N/A
- EPS Growth
- ELP 43.89
- LNTH 304.57
- EPS
- ELP 0.19
- LNTH 6.02
- Revenue
- ELP $4,076,906,276.00
- LNTH $1,496,799,000.00
- Revenue This Year
- ELP N/A
- LNTH $19.64
- Revenue Next Year
- ELP $9.07
- LNTH $5.16
- P/E Ratio
- ELP $7.61
- LNTH $15.62
- Revenue Growth
- ELP 4.83
- LNTH 24.15
- 52 Week Low
- ELP $5.72
- LNTH $50.20
- 52 Week High
- ELP $8.51
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ELP 53.28
- LNTH 53.53
- Support Level
- ELP $5.92
- LNTH $89.92
- Resistance Level
- ELP $6.09
- LNTH $97.25
- Average True Range (ATR)
- ELP 0.11
- LNTH 3.42
- MACD
- ELP 0.05
- LNTH 0.05
- Stochastic Oscillator
- ELP 93.41
- LNTH 67.86
About ELP Companhia Paranaense de Energia (COPEL) (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Holding and Services. Majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.